Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk

Author： Wolozinsky Mia   Yavin Yshai Y.   Cohen Alexander T.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.6, 2005-01, pp. : 409-415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin: In the Prevention of Venous Thromboembolism in Medical Patients

By Warner G.T.   Perry C.M.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 477-481

Adis International

Access to resources Recommend Favorite

Pharmacological Prevention of Thromboembolism in Patients with Left Ventricular Dysfunction

By Thatai Deepak  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 1, 2006-01 ,pp. : 41-49

Adis International

Access to resources Recommend Favorite

Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients: A Systematic Review and Meta-Analysis

By >   >   >   >   Lip Gregory Y.H.  

Drugs, Vol. 72, Iss. 13, 2012-09 ,pp. : 1755-1764

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery

By Schulman Sam   Majeed Ammar  

Drug Safety, Vol. 34, Iss. 6, 2011-06 ,pp. : 449-463

Adis International

Access to resources Recommend Favorite

Bevacizumab: increased risk of venous thromboembolism

By  

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite